Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-05-017601
Filing Date
2005-09-13
Accepted
2005-09-13 14:45:51
Documents
8
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c98340e10vk.htm 10-K 554485
2 EX-10.27 SEPARATION AGREEMENT c98340exv10w27.htm EX-10.27 19466
3 EX-23.1 CONSENT OF GRANT THORNTON LLP c98340exv23w1.htm EX-23.1 2136
4 EX-31.1 CERTIFICATION OF CEO PURSUANT TO SECTION 302 c98340exv31w1.htm EX-31.1 8730
5 EX-31.2 CERTIFICATION OF CFO PURSUANT TO SECTION 302 c98340exv31w2.htm EX-31.2 8959
6 EX-32.1 CERTIFICATION OF CEO PURSUANT TO SECTION 906 c98340exv32w1.htm EX-32.1 3205
7 EX-32.2 CERTIFICATION OF CFO PURSUANT TO SECTION 906 c98340exv32w2.htm EX-32.2 3281
8 EX-99.1 RISK FACTORS c98340exv99w1.htm EX-99.1 24795
  Complete submission text file 0000950134-05-017601.txt   626557
Mailing Address
Business Address 3515 LYMAN BLVD CHASKA MN 55318-3051 6123684300
LIFECORE BIOMEDICAL INC (Filer) CIK: 0000028626 (see all company filings)

EIN.: 410948334 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-04136 | Film No.: 051082021
SIC: 2836 Biological Products, (No Diagnostic Substances)